David Wheadon, M.D.
Board Member
Vaxart, Inc. (VXRT)Equibles does not estimate personal net worth.
Get an email with a short summary when Vaxart, Inc. publishes a filing, an earnings call transcript or a press release.
Get VXRT alertsAbout David Wheadon, M.D.
David Wheadon, M.D. is recorded as Board Member at Vaxart, Inc. (VXRT) since June 11, 2024. Vaxart, Inc. reported in an 8-K filed June 13, 2024 that David Wheadon, M.D. was appointed Director, effective June 11, 2024. Vaxart, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vaxart, Inc. includes Andrei Floroiu (CEO), Michael Finney (CEO), Michael J. Finney (CEO and Board Member) and 7 others.
“Stockholders elected the six nominees for directors to serve until the Company's 2025 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified.”
Affiliation history
-
Current
2024-06-11–present
-
Vaxart, Inc. (VXRT)
SEC 8-K
Current2021-04-21–present
Company network
Leadership on record at Vaxart, Inc.
- Andrei Floroiu CEO
- Michael Finney CEO
- Michael J. Finney CEO, Board Member
- Steven Lo CEO, Board Member
- Fuad Ahmad CFO
- Phillip E. Lee CFO, Chief Accounting Officer
- Edward Berg General Counsel
- Jeroen Grasman Chief Accounting Officer
- David Wheadon Board Member
- Elaine J. Heron Board Member